NCT02074449View on ClinicalTrials.gov

Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil (Remodulin)

CompletedOBSERVATIONAL

Enrollment

15

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Pulmonary Arterial Hypertension

Trial Locations (1)

85724

University of Arizona, Tucson

Sponsors

Collaborators (1)

United Therapeutics

All Listed Sponsors

collaborator

United Therapeutics

INDUSTRY

lead

University of Arizona

OTHER